AM
Therapeutic Areas
Scarcell Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| aGF | Osteoarthritis | Phase 1 |
| aGF Platform | Vascular Diseases | Pre-clinical |
Leadership Team at Scarcell Therapeutics
PA
Pr Antoine Lafont
Founder
SS
Sarah Sorrel
CEO
OH
Ouassila Habi
CSO
GS
Gordon Stewart
Director, US Strategy and Operations
SL
Stefanie Leeflang
Director of Clinical
CS
Caroline Stalla
Director of Finance and Administration
EB
Emeline Belle
Study Engineer